Learn More
Medchemexpress LLC Falnidamol | 196612-93-8 | MFCD09838900 | 99.4% | 387.84 g·mol⁻¹ | C18H19ClFN7 | 50 MG

Supplier: Medchemexpress LLC HY1032250MG
Falnidamol (BIBX 1382) is an orally active, selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used in preclinical research to probe EGFR-dependent signaling and cancer cell proliferation. It exhibits potent EGFR inhibition and is supplied as a characterized research compound for laboratory studies.
- Potent EGFR inhibition with low nanomolar activity.
- Useful for studies of EGFR-driven cancer cell signaling.
- Supplied as a high-purity, analytically characterized research chemical.
- Available in small quantities suitable for screening and dosing experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.